TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
MALVERN, Pa., April 08, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced Howard N. Langstein, MD, FACS, as Vice President of Medical Affairs and Surgeon Strategy. Dr. Langstein is the former Chief of Plastic and Reconstructive Surgery at the University of Rochester Medical Center, known for his extensive expertise, especially in microvascular reconstruction and innovative approaches to complex surgical problems. Dr. Langstein previously held the position of Associate Professor of Plastic Surgery at the University of Texas MD Anderson Cancer Center, where he served as Director of Graduate Medical Education Programs and leader of a world-renowned microsurgical training program. Dr. Langstein brings a tremendous depth of experience, based on extensive training in General Surgery at Bellevue Hospital in New York City, Surgical Oncology at the National Cancer Institute, Plastic Surgery at the Institute of Reconstructive Plastic Surgery at NYU, and Microvascular Surgery at MD Anderson Cancer Center.